Welcure Drugs and Pharmaceuticals has informed that the Company has scheduled to hold its Board Meeting and Audit Committee Meeting on Monday, 30th Day of July 2018, to consider and approve the Un-Audited financial results for the quarter ended on 30.06.2018 and any other matter by the permission of the Chairman of the meeting.
The above information is a part of company’s filings submitted to BSE.